ArticleVaccines2023

Safety, Tolerability, and Immunogenicity of Booster Dose with MVC-COV1901 or MVC-COV1901-Beta SARS-CoV-2 Vaccine in Adults: A Phase I, Prospective, Randomized, Open-Labeled Study.

Chia En Lien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.